Results 271 to 280 of about 2,763,581 (350)

Chronic urticaria treatment challenges in children. [PDF]

Rev Paul Pediatr
Ensina LF, Brandão LS, Melo ACDB, Antila M, Ben-Shoshan M, Solé D.   +5 more
europepmc   +1 more source

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Omalizumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite H1 Antihistamine Therapy

Novartis
openalex   +1 more source

Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study

Journal of Internal Medicine, EarlyView.
Abstract Background Granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) are distinct forms of antineutrophil cytoplasm antibody (ANCA)‐associated vasculitis (AAV). Increasing evidence suggests overlapping features, particularly in proteinase 3 (PR3)‐ANCA‐positive EGPA and GPA with eosinophilia.
Federica Pallotti, Camille Mettler, Matthias Papo, Michele Iudici, Roberto Padoan, Boris Sorin, Francesca Regola, Franco Franceschini, Sergey Moiseev, Pavel Novikov, Mario Andrea Piga, Gianluca Moroncini, Silke R. Brix, Abdul Hadi Kafagi, Samuel Deshayes, Achille Aouba, Julien Campagne, Paolo Delvino, Jan Willem Cohen Tervaert, Luisa Brussino, Martin Michaud, Nils Venhoff, Federico Alberici, Claudia Iannone, Sophie Rosenstingl, Marin Moutel, Jean‐Marc Galempoix, Vincent Cottin, Clara Jaccard, Diane Riehl, Paul Legendre, Anne Claire Billet, Paola Parronchi, Luca Quartuccio, Vitor Teixeira, Allyson Egan, David Jayne, Enrico Tombetti, Marco Caminati, Christian Pagnoux, Alexis Regent, Marc Ruivard, Loïc Guillevin, Xavier Puéchal, Benjamin Terrier, the French Vasculitis Study Group (FVSG)   +45 more
wiley   +1 more source

Association between circulating thyroperoxidase (TPO), anti-TPO IgE, anti-TPO IgG, and different clinical outcomes in chronic urticaria: A hypothesis-generating study. [PDF]

World Allergy Organ J
Lopez JF, Bedoya V, Arango JC, Naranjo TW, Garcia E, Sanchez J.   +5 more
europepmc   +1 more source

Full‐Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) Improves Symptoms of Rett Syndrome: An Open‐Label Study

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim The aim of this Phase I/II open‐label study was to assess the safety and efficacy of NTI164, a novel full‐spectrum medicinal cannabis plant extract 0.08% Δ‐9‐tetrahydrocannabinol (THC), in Rett syndrome (RTT). Methods Eleven female participants (5–16 years) with a pathogenic variant in the MECP2 gene were recruited to this study, receiving
B. A. Keating, Y. Ogru, T. G. Duthy, L. Douglas, K. Lichkus, E. Isikgel, M. C. Fahey, C. Ellaway   +7 more
wiley   +1 more source

Alterations in Gut Microbiota Composition Are Related to Disease Severity and Systemic Inflammation in Patients With Chronic Urticaria. [PDF]

Allergy
Park HK, Her Y, Choi DY, Park T, Kwon JW.   +4 more
europepmc   +1 more source

Feasibility and Patient Experiences in a WhatsApp‐Based Educational Pilot for Spanish‐Speaking Adults With Chronic Spontaneous Urticaria

International Journal of Dermatology, EarlyView.
Elise Edwards, Carlos Lange Nava, Jemima Constanza, Alison Tran, William Abramovits, Gil Yosipovitch   +5 more
wiley   +1 more source

Digitalizing Newspaper Journalism: Instituting and Negotiating New Temporalities in the Digital Workplace

New Technology, Work and Employment, EarlyView.
ABSTRACT Digitalization of the labour process has occasioned the emergence of new temporal orders at work. For newspaper journalists, it has resulted in a radical reorganization of newsrooms and the temporalities of news production, offering a key site for studying this process of temporal reordering.
Xanthe Whittaker
wiley   +1 more source

Prevalence of Mental Health Symptoms in Chronic Urticaria: A Systematic Review and Meta-Analysis. [PDF]

Allergy
Rayner DG, Gou D, Weiler L, Irelewuyi L, Xiong G, Wang E, Sivanesanathan T.   +6 more
europepmc   +1 more source

Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review

Pediatric Dermatology, EarlyView.
ABSTRACT We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average of 2 months and permitted discontinuation of ...
Janis Chang, Aliyah King, Adam Byrne, Carmen Liy‐Wong   +3 more
wiley   +1 more source